Abstract
Cardiovascular disease remains the most common cause of death worldwide, yet there is a wide variation in disease prevalence between different ethnic groups. Ones individual risk is not entirely explained by ‘traditional’ risk factors and this, along with the observation that endogenous and lifestyle risk factors appear to cluster in the same individuals has led to the idea that there may be a common mechanism underlying this disease. It has been postulated that inflammatory pathways may be important. Results from our own and other studies have demonstrated that there may be ethnic differences in the level of circulating inflammatory markers which may be partially related to demographic, lifestyle or genetic factors. Before it is possible to add inflammatory markers to global risk scores it is imperative that a clear understanding of their function, normal range and major determinants in different ethnic groups is established. To date the ethnic research in this area has been very sparse and further work is urgently required. The usefulness of these inflammatory markers in the diagnosis and prognosis of disease in these different populations also needs to be investigated before therapeutic strategies can be fully developed.
Keywords: Inflammation, ethnicity, cardiovascular disease, cytokines, innate immunity, cardiovascular risk
Current Medicinal Chemistry
Title: Ethnicity and Inflammatory Pathways - Implications for Vascular Disease, Vascular Risk and Therapeutic Intervention
Volume: 14 Issue: 13
Author(s): M. A. Miller and F. P. Cappuccio
Affiliation:
Keywords: Inflammation, ethnicity, cardiovascular disease, cytokines, innate immunity, cardiovascular risk
Abstract: Cardiovascular disease remains the most common cause of death worldwide, yet there is a wide variation in disease prevalence between different ethnic groups. Ones individual risk is not entirely explained by ‘traditional’ risk factors and this, along with the observation that endogenous and lifestyle risk factors appear to cluster in the same individuals has led to the idea that there may be a common mechanism underlying this disease. It has been postulated that inflammatory pathways may be important. Results from our own and other studies have demonstrated that there may be ethnic differences in the level of circulating inflammatory markers which may be partially related to demographic, lifestyle or genetic factors. Before it is possible to add inflammatory markers to global risk scores it is imperative that a clear understanding of their function, normal range and major determinants in different ethnic groups is established. To date the ethnic research in this area has been very sparse and further work is urgently required. The usefulness of these inflammatory markers in the diagnosis and prognosis of disease in these different populations also needs to be investigated before therapeutic strategies can be fully developed.
Export Options
About this article
Cite this article as:
Miller A. M. and Cappuccio P. F., Ethnicity and Inflammatory Pathways - Implications for Vascular Disease, Vascular Risk and Therapeutic Intervention, Current Medicinal Chemistry 2007; 14 (13) . https://dx.doi.org/10.2174/092986707780831131
DOI https://dx.doi.org/10.2174/092986707780831131 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Novel Cardiovascular Therapeutics From Small Regulatory RNA Molecules - An Outline of Key Requirements
Current Pharmaceutical Design Cross-Talk Between Mesenchymal Stem/Stromal Cells and Dendritic Cells
Current Stem Cell Research & Therapy Biological Activities of Yarrow Species (Achillea spp.)
Current Pharmaceutical Design Development of Pyrazole Compounds as Antidiabetic Agent: A Review
Letters in Drug Design & Discovery Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design EDITORIAL [Hot Topic: Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Ophthalmic Conditions (Guest Editor: Michael W. Stewart)]
Current Drug Therapy Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway
CNS & Neurological Disorders - Drug Targets Current Approach to the Diagnosis and Treatment of Femoral-Popliteal Arterial Disease. A Systematic Review
Current Cardiology Reviews Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Current Proteomics Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
Current Drug Targets (Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design Metabolic Syndrome and Cognitive Decline
Current Alzheimer Research Onconeural Versus Paraneoplastic Antigens?
Current Medicinal Chemistry Myocardial Perfusion and Coronary Vasomotor Function: Emerging Role of PET Imaging
Vascular Disease Prevention (Discontinued) Antioxidant Vitamins and Cardiovascular Disease
Current Topics in Medicinal Chemistry Editorial (Should Chronic Kidney Disease be Considered as a Coronary Heart Disease Equivalent?)
Current Vascular Pharmacology Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders
Current Medicinal Chemistry Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti-Vascular Endothelial Growth Factors
Current Drug Safety Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis
Current Medicinal Chemistry Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease
Current Topics in Medicinal Chemistry